CELECOXIB
- Product NDC
- 70934-213
- 11-digit product format
- 709340213
- Labeler code
- 70934
- Product ID
- 70934-213_f1623deb-4a79-3e68-e053-2a95a90aec16
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA204776
- Marketing category
- ANDA
- Marketing start
- 2018-12-27
- Marketing end
- 2023-04-30
- Substance
- CELECOXIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-213-30 | 70934021330 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-213-30) | 30 capsule | 2018-12-27 | 0000-00-00 | No | No | Current |
| 70934-213-60 | 70934021360 | 60 CAPSULE in 1 BOTTLE, PLASTIC (70934-213-60) | 60 capsule | 2019-08-19 | 0000-00-00 | No | No | Current |
| 70934-213-90 | 70934021390 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70934-213-90) | 90 capsule | 2018-06-05 | 0000-00-00 | No | No | Current |